| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |